ISRCTN71629284已完成不适用
Does N-Acetylcysteine (Parvolex®) prophylaxis reduce the incidence of renal impairment after onpump Coronary Artery Bypass Graft surgery? A prospective randomised controlled trial
niversity Hospital of South Manchester NHS Foundation Trust (UK)0 个研究点目标入组 224 人开始时间: 2007年8月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 224
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients undergoing elective coronoray artery bypass surgery (onpump) at Wythenshawe Hospital
- •2. Aged 21 - 80 years
排除标准
- •1. Urgent or emergency cases
- •2. History of hypersensitivity to N-Acetylcysteine
- •3. Patients already taking N-Acetylcysteine
- •4. Patients with renal failure
研究者
相似试验
进行中（未招募）
1 期
Does N-Acetylcysteine (Parvolex) prophylaxis reduce the incidence of renal impairment after on pump Coronary artery bypass surgery? A prospective randomised controlled trial.Renal impairment after coronary artery byapass surgeryMedDRA version: 9.1Level: LLTClassification code 10006894Term: CABGEUCTR2006-006815-62-GBniversity Hospitals of South Manchester NHS Foundation Trust224
已完成
不适用
Does prophylactic N-AcetylCysteine decrease incidence of contrast nephropathy in patients undergoing peripheral angiography?Contrast induced nephropathyUrological and Genital DiseasesNephropathyISRCTN35882618Cambridge University Hospital NHS Trust (UK)40
已完成
不适用
Does prophylactic N acetylcysteine decrease the incidence of contrast nephropathy in patients undergoing endovascular abdominal aortic aneurysm (AAA) repair?Surgery: Abdominal aortic aneurysm (AAA) repairSurgeryAbdominal aortic aneurysm (AAA) repairISRCTN69248640Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)20
进行中（未招募）
1 期
Does prophylactic N acetylcysteine reduce the incidence of contrast nephropathy in patients undergoing peripheral angiography - NAC as a Nehroprotective agent in Peripheral AngiographyEUCTR2005-005809-38-GBResearch & Development Department, Addenbrookes Hospital40
已完成
不适用
Evaluating N-acetylcysteine efficacy in the prevention of amphotericin B-induced nephrotoxicityFungal infections.Certain infectious and parasitic diseasesB37? B38 ?IRCT201107233449N8Tehran University of Medical Sciences60